ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
7,918.90
0.00%
S&P ASX All Technology
3,537.00
0.00%
Brent Oil
71.865
1.84%
US Dollar vs AUD
1.58687
0.99%
Bitcoin
84,341.24
-2.94%
Pepperstone
Advertisement
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. GenSight Biologics S.A. (SIGHT) Share Price

GenSight Biologics S.A.

GenSight Biologics S.A. (SIGHT)

EU
0.236
-0.0205
(-7.99%)
Closed 21 March 3:30AM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
0.236
Bid
0.236
Offer
0.24
Volume
542,434
0.23 Day's Range 0.255
0.2005 52 Week Range 0.496
Market Cap
18.495M
Previous Close
0.2565
Open
0.255
Last Trade
549
@
0.236
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
217,381
Shares Outstanding
78,370,724
Dividend Yield
-
PE Ratio
-0.72
Earnings Per Share (EPS)
-0.33
Revenue
2.96M
Net Profit
-26.22M

About GenSight Biologics S.A.

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.gensight-biologics.com
Headquarters
Paris, Paris, Fra
Founded
-
GenSight Biologics S.A. is listed in the Biological Pds,ex Diagnstics sector of the Euronext with ticker SIGHT. The last closing price for GenSight Biologics was 0.26 €. Over the last year, GenSight Biologics shares have traded in a share price range of 0.2005 € to 0.496 €.

GenSight Biologics currently has 78,370,724 shares in issue. The market capitalisation of GenSight Biologics is 20.10 € million. GenSight Biologics has a price to earnings ratio (PE ratio) of -0.72.

Ask ADVFN Intelligence (AI)

SIGHT Latest News

More News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.02-7.81250.2560.26450.231550530.25308068DE
4-0.028-10.60606060610.2640.2660.20052049870.24486757DE
12-0.046-16.31205673760.2820.31950.20052173810.27505381DE
26-0.154-39.48717948720.390.4440.20052947600.3147714DE
52-0.242-50.62761506280.4780.4960.20052416470.34172744DE
156-3.152-93.03423848883.3884.5880.20052117021.04292161DE
260-1.488-86.31090487241.7249.6950.20052643203.08528508DE

SIGHT - Frequently Asked Questions (FAQ)

What is the current GenSight Biologics share price?
The current share price of GenSight Biologics is 0.236 €
How many GenSight Biologics shares are in issue?
GenSight Biologics has 78,370,724 shares in issue
What is the market cap of GenSight Biologics?
The market capitalisation of GenSight Biologics is EUR 20.1M
What is the 1 year trading range for GenSight Biologics share price?
GenSight Biologics has traded in the range of 0.2005 € to 0.496 € during the past year
What is the PE ratio of GenSight Biologics?
The price to earnings ratio of GenSight Biologics is -0.72
What is the cash to sales ratio of GenSight Biologics?
The cash to sales ratio of GenSight Biologics is 6.35
What is the reporting currency for GenSight Biologics?
GenSight Biologics reports financial results in EUR
What is the latest annual turnover for GenSight Biologics?
The latest annual turnover of GenSight Biologics is EUR 2.96M
What is the latest annual profit for GenSight Biologics?
The latest annual profit of GenSight Biologics is EUR -26.22M
What is the registered address of GenSight Biologics?
The registered address for GenSight Biologics is 74, RUE DU FAUBOURG SAINT-ANTOINE, PARIS, PARIS, 75012
What is the GenSight Biologics website address?
The website address for GenSight Biologics is www.gensight-biologics.com
Which industry sector does GenSight Biologics operate in?
GenSight Biologics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
DMSBSDiagnostic Medical Systems
0.01 €
(150.00%)
1
ALTHOMetavisio (Thomson Computing)
0.05 €
(39.66%)
4.22M
MLONLOnlineformapro
1.10 €
(20.88%)
1,000
MLACTActivium Group
1.57 €
(19.85%)
1
ENVIEnvipco Holdings NV
6.20 €
(15.89%)
262.42k
SGDDSSpineguard DS
0.0002 €
(-50.00%)
2.8M
PHRPHarol SGPS SA
0.0602 €
(-47.42%)
127.12M
HAFDSHaffner Energy DS
0.0215 €
(-33.64%)
366.16k
MLOCTOctopus Biosafety
0.10 €
(-27.54%)
978
PHXMPHAXIAM Therapeutics SA
1.00 €
(-27.43%)
308.89k
ATOAtos SE
0.0037 €
(0.00%)
437.53M
ALCYBCybergun
0.0002 €
(0.00%)
430.09M
PHRPHarol SGPS SA
0.0602 €
(-47.42%)
127.12M
BCPBanco Comercial Portugues SA
0.5498 €
(-4.71%)
121.43M
ALEUPEuroplasma
0.0111 €
(-13.28%)
98.67M

Discussion

View Full Feed
georgie18 georgie18 5 minutes ago
My scan didn't pick it up either and there was not one post onit during the trading day...🥳
jimr1717 jimr1717 5 minutes ago
But but wait! It’s the “ The Holy Grail”! No One is Fooled
IFUS
Slojab Slojab 5 minutes ago
Just take your loss and move on.
JNSH
littlejohn littlejohn 6 minutes ago
SMCI below $80 with AI Booming now

shows the manipulated bullchit

against it just won't quit...

Took a huge, quick percentage loss

in oil companies under Trump and

it should be the last...

Trump killed oil stoc
SMCI
dinogreeves dinogreeves 6 minutes ago
That is what I hoping for, I am also hoping from 4 ships to 3 ships doesn't change/delay the permits. Fingers crossed we get to that finish line at least with the permits for now.
TGLO
meidiot meidiot 6 minutes ago
Fifty 1 Labs, Inc. (FITY) Acquires Genetic Networks, Working to Secure Multi-Million Dollar DoD Contracts, and Positions for Rapid Expansion in Biotech Innovation
Press Release | 03/20/2025
MELBOURNE, Fla., March 20, 2025 (GLOBE NEWSWIRE) -- via IBN -- Fifty 1 Labs, Inc. (OTC: FITY), a
FITY
Scotttrader80 Scotttrader80 7 minutes ago
The PEBBLE MINE does NOT contain the critical minerals the TRUMP administrations is seeking. Get it through your heads

What minerals are in Pebble Mine?
The current resource estimate includes 6.5 billion tonnes in the measured and indicated categories and 4.5 billion tonnes in
NAK
zeusgodmd zeusgodmd 7 minutes ago
Triple witching Friday. Anything can happen
RNAZ
Ecomike Ecomike 8 minutes ago
Test data of SGP+(tm) of samples SURAC collected that the folks that tested at the ORNL, OakRidge National Labs, the folks that invented the A-Bomb, was published on the IFUS Website before Marc and Trey left for India, to close the India JV deal, which by the way went better than we dreamed possibl
IFUS
xodcode xodcode 9 minutes ago
NPV is tough. Like doing NPV on Schrodingers cat.

No doubt about the fact that NPV predictions are tough! No dispute there. But, my guess, based upon my estimate of 80% to 90% chance of EMA approval is that NPV is much greater than $10.04. That's exactly why I am extremely bullish on
AVXL
dennisdave dennisdave 10 minutes ago
Uhm, not in this version of the universe where Switzerland is not in the EU.
EMA approval significantly influences Swissmedic's decisions, but yes it does not guarantee automatic approval in Switzerland.
Read between the lines with your other universe

More importantly,
NWBO
fuagf fuagf 10 minutes ago
LOL No way. Never happened. https://www.democraticunderground.com/emoticons/nopity.gif
dirkv dirkv 11 minutes ago
LICHEN CHINA LTD (LICN): 4.40 + 8.633%
mktcap : less than 3.2 million, cash 34.2 million, assets 49.2 million.
52W: 4.15 – 488

Total Cash (mrq) 34.19M
Total Debt (mrq) 82k
Shares Outstanding 712.17k
Market Cap 3.14M

Mar 17, 2025
LICN
Poo28 Poo28 11 minutes ago
Astonishing to real shareholders these self-proclaimed cognoscenti who will tell us how important they are, but have time to opine on chat room. Truly lsughable, “look at me,” I deign to tell you what to do . Boggles the mind.

DBMM through its brand Digital Clarity an and its manage
DBMM OTCM
Bubae Bubae 11 minutes ago
Yeah, I agree with that. Apply a little common sense. 😆 This is for those conducting their own due diligence. This hasn't been able to recover since the massive sell off March 6th with 512 million shares traded for the day. One of 166 million shares in just three minutes of trading back on M
COMMON SENSE
dirkv dirkv 11 minutes ago
LICHEN CHINA LTD (LICN): 4.40 + 8.633%
mktcap : less than 3.2 million, cash 34.2 million, assets 49.2 million.
52W: 4.15 – 488

Total Cash (mrq) 34.19M
Total Debt (mrq) 82k
Shares Outstanding 712.17k
Market Cap 3.14M

Mar 17, 2025
LICN
Paulie Cashews Paulie Cashews 11 minutes ago
💟 Hap! Did you use this pick-up line to meet your last wife:

"Hey, baby! You better call Life Alert®, because I've fallen for you and I can't get up!"

adserv.stocksite.com/images/paulie/haplago.jpg

www.investorshub.com/boards/board.asp?board
Blue Diamonds Blue Diamonds 12 minutes ago
I get the same thing
SANP
stoxjock stoxjock 12 minutes ago
Just Repeating same things???...We all did the same things, BOZO...Looks like your Brain Fog increasing day-by-day and your Confusion is increasing and Speech is SLURRY and you are grasping for Words...Hence, seems the Repetition & Regurgitation...Please get immediate Medical Help...God Bless!
COOP
MC10459 MC10459 12 minutes ago
.0003 
HMBL
newmedman newmedman 12 minutes ago
just don't go buying two shirts and a pair of socks because the sales girl winks at you. Stay focused.
JAB65 JAB65 12 minutes ago
Assuming receipt of the MARAD license in the next day or two, the semi-annual report that Chen referenced will be a most interesting read. That report could/should lay out a fairly reliable timeline to get excited about.

Link:
https://www.energy.gov/fecm/articles/semi-annual-r
TGLO
velcro velcro 13 minutes ago
Moving up on low Volume, likely due to Vancouver stadium business and Reflect warrant strike price at $3.25
CREX
6of1 6of1 14 minutes ago
couldnt have been very positive
QBTS
STRIKERGR21 STRIKERGR21 14 minutes ago
This has a long way to go just to get back to the high of a year back. And that’s not great achievement. Pump and dump then and now. Nothing about INKW says invest in me. The lies the deceptions and mismanagement will continue. No product awareness no Audits false and misleading PR’s stock deludin
INKW

Your Recent History

EU
SIGHT
GenSight Biologics
Delayed Upgrade Clock
ADVFN Logo
Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads